Advancing clinical trial design in pulmonary hypertension

In pulmonary hypertension, as in many other diseases, there is a need for a smarter approach to evaluating new treatments. The traditional randomized controlled trial has served medical science well, but constrains the development of treatments for rare diseases. A workshop was established to consid...

Descripción completa

Detalles Bibliográficos
Autores principales: Grieve, Andy P., Chow, Shien-Chung, Curram, John, Dawe, Stephen, Harnisch, Lutz O., Henig, Noreen R., Hung, Hsien Ming J., Ivy, D. Dunbar, Kawut, Steven M., Rahbar, Mohammad H., Xiao, Shen, Wilkins, Martin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2013
Materias:
Pulmonary Hypertension–Academic Research Consortium: Novel Clinical Trial Designs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641733/
https://www.ncbi.nlm.nih.gov/pubmed/23662200
http://dx.doi.org/10.4103/2045-8932.109933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641733/
https://www.ncbi.nlm.nih.gov/pubmed/23662200
http://dx.doi.org/10.4103/2045-8932.109933

Ejemplares similares